# Fitlife Brands, Inc.: filings

FTLF · Nasdaq · CIK 1374328 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ftlf.md) · [Financials](/companies/ftlf/financials.md) · [Filings](/companies/ftlf/filings.md) · [Insiders](/companies/ftlf/insiders.md)

## Reports and events: 246 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 147, 4 140, 10-Q 53, SC 13G/A 22, 3 19, 10-K 18, DEF 14A 11, 5 9, CORRESP 9, 10-K/A 7, NT 10-K 7, SC 13D/A 7, UPLOAD 7, 425 6, 4/A 6, NT 10-Q 6, DEFA14A 5, SC 13G 5, D 3, 8-K/A 2, EFFECT 2, PRE 14A 2, S-8 2, SCHEDULE 13G/A 2, 15-12G 1, 15-12G/A 1, 3/A 1, 424B3 1, 8-A12B 1, CERT 1, PRER14A 1, S-3 1, S-4 1, S-4/A 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-09 | 16:06 ET | [8-K](/filings/0001437749-26-029979.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-029979 |
| 2026-08-13 | 08:30 ET | [8-K](/filings/0001437749-26-027493.md) | 2.02 Results of operations; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-027493 |
| 2026-08-13 | 07:30 ET | [10-Q](/filings/0001437749-26-027478.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027478 |
| 2026-06-26 | 12:15 ET | [DEF 14A](/filings/0001437749-26-021797.md) | Proxy statement, period 2026-08-11 | 0001437749-26-021797 |
| 2026-05-22 | 16:09 ET | [8-K](/filings/0001437749-26-018249.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-018249 |
| 2026-05-14 | 14:00 ET | [8-K](/filings/0001437749-26-016983.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-016983 |
| 2026-05-14 | 07:30 ET | [10-Q](/filings/0001437749-26-016875.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016875 |
| 2026-04-21 | 17:00 ET | [10-K/A](/filings/0001437749-26-012937.md) | Annual report, amended, period 2025-12-31 | 0001437749-26-012937 |
| 2026-04-07 | 16:23 ET | [8-K](/filings/0001437749-26-011607.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-011607 |
| 2026-04-01 | 08:00 ET | [8-K](/filings/0001437749-26-010811.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-010811 |
| 2026-03-31 | 16:30 ET | [10-K](/filings/0001437749-26-010680.md) | Annual report, period 2025-12-31 | 0001437749-26-010680 |
| 2025-12-10 | 08:02 ET | [8-K](/filings/0001437749-25-037314.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-037314 |
| 2025-11-13 | 07:45 ET | [8-K](/filings/0001437749-25-034610.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-034610 |
| 2025-11-13 | 07:30 ET | [10-Q](/filings/0001437749-25-034607.md) | Quarterly report, period 2025-09-30 | 0001437749-25-034607 |
| 2025-10-20 | 07:30 ET | [8-K/A](/filings/0001437749-25-031312.md) | 9.01 Financial statements and exhibits | 0001437749-25-031312 |
| 2025-08-19 | 16:30 ET | [8-K](/filings/0001437749-25-027367.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-027367 |
| 2025-08-14 | 07:30 ET | [8-K](/filings/0001437749-25-026674.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-026674 |
| 2025-08-14 | 07:00 ET | [10-Q](/filings/0001437749-25-026661.md) | Quarterly report, period 2025-06-30 | 0001437749-25-026661 |
| 2025-08-13 | 16:49 ET | [8-K](/filings/0001437749-25-026555.md) | 5.07 Shareholder vote results | 0001437749-25-026555 |
| 2025-08-11 | 07:30 ET | [8-K](/filings/0001437749-25-025813.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-025813 |
| 2025-08-05 | 07:05 ET | [8-K](/filings/0001437749-25-024707.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-024707 |
| 2025-06-24 | 17:00 ET | [DEF 14A](/filings/0001437749-25-021173.md) | Proxy statement, period 2025-08-12 | 0001437749-25-021173 |
| 2025-05-15 | 08:00 ET | [8-K](/filings/0001437749-25-016991.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-016991 |
| 2025-05-15 | 07:30 ET | [10-Q](/filings/0001437749-25-016990.md) | Quarterly report, period 2025-03-31 | 0001437749-25-016990 |
| 2025-04-29 | 18:43 ET | [10-K/A](/filings/0001437749-25-013385.md) | Annual report, amended, period 2024-12-31 | 0001437749-25-013385 |
| 2025-04-28 | 08:00 ET | [8-K](/filings/0001437749-25-013231.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-013231 |
| 2025-04-22 | 07:30 ET | [8-K](/filings/0001437749-25-012595.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-012595 |
| 2025-03-27 | 14:38 ET | [8-K](/filings/0001437749-25-009584.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-009584 |
| 2025-03-27 | 07:38 ET | [10-K](/filings/0001437749-25-009469.md) | Annual report, period 2024-12-31 | 0001437749-25-009469 |
| 2025-03-13 | 08:45 ET | [8-K](/filings/0001437749-25-007389.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-007389 |
| 2025-02-05 | 17:11 ET | [8-K](/filings/0001437749-25-002916.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-002916 |
| 2024-12-16 | 08:00 ET | [8-K](/filings/0001437749-24-037519.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-037519 |
| 2024-11-18 | 08:15 ET | [8-K](/filings/0001437749-24-035540.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-035540 |
| 2024-11-14 | 07:45 ET | [8-K](/filings/0001437749-24-035028.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-035028 |
| 2024-11-14 | 07:30 ET | [10-Q](/filings/0001437749-24-035027.md) | Quarterly report, period 2024-09-30 | 0001437749-24-035027 |
| 2024-08-14 | 16:18 ET | [8-K](/filings/0001437749-24-026822.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-026822 |
| 2024-08-14 | 07:30 ET | [10-Q](/filings/0001437749-24-026562.md) | Quarterly report, period 2024-06-30 | 0001437749-24-026562 |
| 2024-07-05 | 08:00 ET | [DEF 14A](/filings/0001437749-24-022224.md) | Proxy statement, period 2024-08-13 | 0001437749-24-022224 |
| 2024-07-05 | 07:30 ET | [8-K](/filings/0001437749-24-022223.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-022223 |
| 2024-05-14 | 07:30 ET | [10-Q](/filings/0001437749-24-016353.md) | Quarterly report, period 2024-03-31 | 0001437749-24-016353 |
| 2024-05-14 | 07:30 ET | [8-K](/filings/0001437749-24-016354.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-016354 |
| 2024-05-08 | 07:30 ET | [8-K](/filings/0001437749-24-015202.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-015202 |
| 2024-04-22 | 11:48 ET | [10-K/A](/filings/0001437749-24-012657.md) | Annual report, amended, period 2023-12-31 | 0001437749-24-012657 |
| 2024-03-29 | 17:17 ET | [10-K](/filings/0001437749-24-010119.md) | Annual report, period 2023-12-31 | 0001437749-24-010119 |
| 2024-03-29 | 16:41 ET | [8-K](/filings/0001437749-24-010094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-010094 |
| 2024-03-15 | 12:47 ET | [8-K](/filings/0001437749-24-008039.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-008039 |
| 2023-11-14 | 08:34 ET | [8-K](/filings/0001437749-23-031771.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-031771 |
| 2023-11-13 | 07:31 ET | [10-Q](/filings/0001437749-23-031385.md) | Quarterly report, period 2023-09-30 | 0001437749-23-031385 |
| 2023-10-13 | 07:30 ET | [8-K](/filings/0001437749-23-028182.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-028182 |
| 2023-09-27 | 17:17 ET | [8-K](/filings/0001437749-23-026948.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-026948 |

Page 1 of 5. [Older](/companies/ftlf/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.